These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 28558021

  • 1. Interactions of sclerostin with FGF23, soluble klotho and vitamin D in renal transplantation.
    Tartaglione L, Pasquali M, Rotondi S, Muci ML, Leonangeli C, Farcomeni A, Fassino V, Mazzaferro S.
    PLoS One; 2017; 12(5):e0178637. PubMed ID: 28558021
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration.
    Milovanova LY, Dobrosmyslov IA, Milovanov YS, Taranova MV, Kozlov VV, Milovanova SY, Kozevnikova EI.
    Ter Arkh; 2018 Jun 20; 90(6):48-54. PubMed ID: 30701904
    [Abstract] [Full Text] [Related]

  • 5. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study.
    Pavik I, Jaeger P, Ebner L, Wagner CA, Petzold K, Spichtig D, Poster D, Wüthrich RP, Russmann S, Serra AL.
    Nephrol Dial Transplant; 2013 Feb 20; 28(2):352-9. PubMed ID: 23129826
    [Abstract] [Full Text] [Related]

  • 6. Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.
    Asamiya Y, Yajima A, Shimizu S, Otsubo S, Tsuchiya K, Nitta K.
    Osteoporos Int; 2015 Mar 20; 26(3):1017-28. PubMed ID: 25366373
    [Abstract] [Full Text] [Related]

  • 7. Early renal impairment affects hormonal regulators of calcium and bone metabolism and Wnt signalling and the response to vitamin D supplementation in healthy older adults.
    Christodoulou M, Aspray TJ, Piec I, Washbourne C, Tang JCY, Fraser WD, Schoenmakers I, VDOP Trial group, Terry J Aspray, Roger M Francis, Elaine McColl, Thomas Chadwick, Ann Prentice, Inez Schoenmakers.
    J Steroid Biochem Mol Biol; 2023 May 20; 229():106267. PubMed ID: 36739953
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Klotho and fibroblast growth factor 23 in cerebrospinal fluid in children.
    Kunert SK, Hartmann H, Haffner D, Leifheit-Nestler M.
    J Bone Miner Metab; 2017 Mar 20; 35(2):215-226. PubMed ID: 27017221
    [Abstract] [Full Text] [Related]

  • 11. The effect of GH treatment on serum FGF23 and Klotho in GH-deficient children.
    Efthymiadou A, Kritikou D, Mantagos S, Chrysis D.
    Eur J Endocrinol; 2016 Apr 20; 174(4):473-9. PubMed ID: 26764419
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The role of vitamin D in the FGF23, klotho, and phosphate bone-kidney endocrine axis.
    Haussler MR, Whitfield GK, Kaneko I, Forster R, Saini R, Hsieh JC, Haussler CA, Jurutka PW.
    Rev Endocr Metab Disord; 2012 Mar 20; 13(1):57-69. PubMed ID: 21932165
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M, Smith C, Shah V, Gullet A, Wells D, Rees L, Shroff R.
    Nephrol Dial Transplant; 2013 Jan 20; 28(1):153-61. PubMed ID: 23180879
    [Abstract] [Full Text] [Related]

  • 15. Bone mineralization is regulated by signaling cross talk between molecular factors of local and systemic origin: the role of fibroblast growth factor 23.
    Sapir-Koren R, Livshits G.
    Biofactors; 2014 Jan 20; 40(6):555-68. PubMed ID: 25352227
    [Abstract] [Full Text] [Related]

  • 16. Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study.
    Lewerin C, Ljunggren Ö, Nilsson-Ehle H, Karlsson MK, Herlitz H, Lorentzon M, Ohlsson C, Mellström D.
    Bone; 2017 May 20; 98():1-8. PubMed ID: 28212898
    [Abstract] [Full Text] [Related]

  • 17. 1,25-Dihydroxyvitamin D3/VDR-mediated induction of FGF23 as well as transcriptional control of other bone anabolic and catabolic genes that orchestrate the regulation of phosphate and calcium mineral metabolism.
    Barthel TK, Mathern DR, Whitfield GK, Haussler CA, Hopper HA, Hsieh JC, Slater SA, Hsieh G, Kaczmarska M, Jurutka PW, Kolek OI, Ghishan FK, Haussler MR.
    J Steroid Biochem Mol Biol; 2007 Mar 20; 103(3-5):381-8. PubMed ID: 17293108
    [Abstract] [Full Text] [Related]

  • 18. Effects of nutritional vitamin D supplementation on markers of bone and mineral metabolism in children with chronic kidney disease.
    Lerch C, Shroff R, Wan M, Rees L, Aitkenhead H, Kaplan Bulut I, Thurn D, Karabay Bayazit A, Niemirska A, Canpolat N, Duzova A, Azukaitis K, Yilmaz E, Yalcinkaya F, Harambat J, Kiyak A, Alpay H, Habbig S, Zaloszyc A, Soylemezoglu O, Candan C, Rosales A, Melk A, Querfeld U, Leifheit-Nestler M, Sander A, Schaefer F, Haffner D, 4C study consortium, ESPN CKD-MBD working group.
    Nephrol Dial Transplant; 2018 Dec 01; 33(12):2208-2217. PubMed ID: 29481636
    [Abstract] [Full Text] [Related]

  • 19. FGF23, klotho and vitamin D interactions: What have we learned from in vivo mouse genetics studies?
    Razzaque MS.
    Adv Exp Med Biol; 2012 Dec 01; 728():84-91. PubMed ID: 22396163
    [Abstract] [Full Text] [Related]

  • 20. Reciprocal control of 1,25-dihydroxyvitamin D and FGF23 formation involving the FGF23/Klotho system.
    Prié D, Friedlander G.
    Clin J Am Soc Nephrol; 2010 Sep 01; 5(9):1717-22. PubMed ID: 20798257
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.